Centiva Capital, LP Emergent Bio Solutions Inc. Transaction History
Centiva Capital, LP
- $4.79 Billion
- Q3 2024
A detailed history of Centiva Capital, LP transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 31,544 shares of EBS stock, worth $292,412. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,544
Previous 84,074
62.48%
Holding current value
$292,412
Previous $573,000
54.1%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding EBS
# of Institutions
158Shares Held
32.9MCall Options Held
424KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$35.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$31.5 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.49MShares$23.1 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.22MShares$20.6 Million0.0% of portfolio
-
State Street Corp Boston, MA1.91MShares$17.7 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $462M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...